IRADIMED CORPORATION to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
August 27 2019 - 4:15PM
IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie
McDonnell, President and Chief Executive Officer, Roger Susi,
Chairman and Chief Technology Officer and Chris Scott, Chief
Financial Officer, will participate in the Morgan Stanley 17th
Annual Global Healthcare Conference in New York from September 9,
2019 to September 11, 2019.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in the development of
innovative magnetic resonance imaging (“MRI”) compatible medical
devices. We are the only known provider of a non-magnetic
intravenous (“IV”) infusion pump system that is specifically
designed to be safe for use during MRI procedures. We were the
first to develop an infusion delivery system that largely
eliminates many of the dangers and problems present during MRI
procedures. Standard infusion pumps contain magnetic and electronic
components which can create radio frequency interference and are
dangerous to operate in the presence of the powerful magnet that
drives an MRI system. Our patented MRidium® MRI compatible IV
infusion pump system has been designed with a non-magnetic
ultrasonic motor, uniquely designed non-ferrous parts and other
special features to safely and predictably deliver anesthesia and
other IV fluids during various MRI procedures. Our pump solution
provides a seamless approach that enables accurate, safe and
dependable fluid delivery before, during and after an MRI scan,
which is important to critically-ill patients who cannot be removed
from their vital medications, and children and infants who must
generally be sedated to remain immobile during an MRI scan.
Our 3880 MRI compatible patient vital signs monitoring system
has been designed with non-magnetic components and other special
features to safely and accurately monitor a patient’s vital signs
during various MRI procedures. The IRADIMED 3880 system operates
dependably in magnetic fields up to 30,000 gauss, which means it
can operate virtually anywhere in the MRI scanner room. The
IRADIMED 3880 has a compact, lightweight design allowing it to
travel with the patient from their critical care unit, to the MRI
and back, resulting in increased patient safety through
uninterrupted vital signs monitoring and decreasing the amount of
time critically ill patients are away from critical care units. The
features of the IRADIMED 3880 include: wireless ECG with dynamic
gradient filtering; wireless SpO2 using Masimo® algorithms;
non-magnetic respiratory CO2; non-invasive blood pressure; invasive
blood pressure; patient temperature, and; optional advanced
multi-gas anesthetic agent unit featuring continuous Minimum
Alveolar Concentration measurements. The IRADIMED 3880 MRI
compatible patient vital signs monitoring system has an easy-to-use
design and allows for the effective communication of patient vital
signs information to clinicians.
For more information please visit www.iradimed.com.
Media Contact:Chris ScottChief Financial OfficerIRADIMED
CORPORATION(407) 677-8022 InvestorRelations@iradimed.com
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Sep 2024 to Oct 2024
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Oct 2023 to Oct 2024